Tags

Type your tag names separated by a space and hit enter

Polypharmacy: droxidopa to treat neurogenic orthostatic hypotension in a patient with Parkinson disease and type 2 diabetes mellitus.
Clin Auton Res. 2017 07; 27(Suppl 1):33-34.CA

Links

Publisher Full Text
ncbi.nlm.nih.gov
dx.doi.org
PMC Free PDF

Authors+Show Affiliations

Vernino S
Department of Neurology and Neurotherapeutics, UT Southwestern, Dallas, TX, USA. steven.vernino@utsouthwestern.edu.
Claassen D
Department of Neurology, University of Southern California, Los Angeles, CA, USA.

MeSH

AgedAntiparkinson AgentsDiabetes Mellitus, Type 2DroxidopaFemaleHumansHypotension, OrthostaticMidodrineParkinson DiseasePolypharmacyVasoconstrictor Agents

Pub Type(s)

Case Reports
Letter

Language

eng

PubMed ID

28674868

Citation

Vernino, Steven, and Daniel Claassen. "Polypharmacy: Droxidopa to Treat Neurogenic Orthostatic Hypotension in a Patient With Parkinson Disease and Type 2 Diabetes Mellitus." Clinical Autonomic Research : Official Journal of the Clinical Autonomic Research Society, vol. 27, no. Suppl 1, 2017, pp. 33-34.
Vernino S, Claassen D. Polypharmacy: droxidopa to treat neurogenic orthostatic hypotension in a patient with Parkinson disease and type 2 diabetes mellitus. Clin Auton Res. 2017;27(Suppl 1):33-34.
Vernino, S., & Claassen, D. (2017). Polypharmacy: droxidopa to treat neurogenic orthostatic hypotension in a patient with Parkinson disease and type 2 diabetes mellitus. Clinical Autonomic Research : Official Journal of the Clinical Autonomic Research Society, 27(Suppl 1), 33-34. https://doi.org/10.1007/s10286-017-0435-5
Vernino S, Claassen D. Polypharmacy: Droxidopa to Treat Neurogenic Orthostatic Hypotension in a Patient With Parkinson Disease and Type 2 Diabetes Mellitus. Clin Auton Res. 2017;27(Suppl 1):33-34. PubMed PMID: 28674868.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Polypharmacy: droxidopa to treat neurogenic orthostatic hypotension in a patient with Parkinson disease and type 2 diabetes mellitus. AU - Vernino,Steven, AU - Claassen,Daniel, Y1 - 2017/07/03/ PY - 2017/06/07/received PY - 2017/06/08/accepted PY - 2017/7/5/pubmed PY - 2019/3/26/medline PY - 2017/7/5/entrez KW - Droxidopa KW - Neurogenic orthostatic hypotension KW - Parkinson disease KW - Type 2 diabetes mellitus SP - 33 EP - 34 JF - Clinical autonomic research : official journal of the Clinical Autonomic Research Society JO - Clin Auton Res VL - 27 IS - Suppl 1 SN - 1619-1560 UR - https://www.unboundmedicine.com/medline/citation/28674868/Polypharmacy:_droxidopa_to_treat_neurogenic_orthostatic_hypotension_in_a_patient_with_Parkinson_disease_and_type_2_diabetes_mellitus_ L2 - http://dx.doi.org/10.1007/s10286-017-0435-5 DB - PRIME DP - Unbound Medicine ER -